Diethmar Antoni

Paclitaxel-Coated Balloon Catheter Versus Paclitaxel-Coated Stent for the Treatment of Coronary In-Stent Restenosis

Martin Unverdorben, C. Vallbracht, Bodo Cremers et al. · Circulation · 2009 · 504 citations · Full text

Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS): 4 year follow-up of a randomised non-inferiority trial

Giulio Stefanini, Bindu Kalesan, Patrick W. Serruys et al. · The Lancet · 2011 · 350 citations

Percutaneous Coronary Intervention, Endovascular Technique, Cardiovascular Disease +8

Improved Safety and Reduction in Stent Thrombosis Associated With Biodegradable Polymer-Based Biolimus-Eluting Stents Versus Durable Polymer-Based Sirolimus-Eluting Stents in Patients With Coronary Artery Disease

Patrick W. Serruys, Vasim Farooq, Bindu Kalesan et al. · JACC: Cardiovascular Interventions · 2013 · 328 citations

Percutaneous Coronary Intervention, Thrombosis, Cardiovascular Disease +7

Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis: the three-year results of the PEPCAD II ISR study

Martin Unverdorben, C. Vallbracht, Bodo Cremers et al. · EuroIntervention · 2015 · 91 citations

Aortic valve calcium score as a predictor for outcome after TAVI using the CoreValve revalving system

Alexander Leber, Markus Kasel, Thomas Ischinger et al. · International Journal of Cardiology · 2011 · 90 citations

Cardiovascular Disease, Cardiac Mechanic, Vascular Surgery +10